Monday, May 31, 2021

Venus Remedies Ltd (526953) – Growing @ 52%

Venus Remedies Ltd  (526953)  closes   at 332.80  with  a   Gain of   +2.0%   on    31-May-2021  with formation of  a  Small  Red  Candle    on Daily  Price Chart.

About the Company : Venus Remedies is engaged in Business of Pharmaceutical product manufacturing.

Strength : Financial Indicators are turning Good.

Financials : Venus Remedies Ltd  has posted Net Sales / Revenue   of  340.00 Cr & Net Loss  of -10.00 Cr in FY2020 and expected to post Net Sales / Revenue   of 520.00 Cr & Net Profit of 21.00Cr in FY2021 .

Valuations  : The Company is now Trading at X 2..60  of its  valuations ( last 4Quaters FY2021 earnings considered here) at ~160% premium  and at X1.20  of its FY 2022, which is now almost  ~20%  Premium to its value .

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  -1.30 which  makes is attractive .  The  Equity Value Per Share ( Enterprise Value Method ) is  332.80

If We factor its earnings/valuations, its Price arrives at 738 with consideration FY2022 earnings.

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source NSE Website | Screener.In  | Capital Line Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

Manage your investments the right way With MProfit. Visit https://www.mprofit.in/

Use Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D


Sunday, May 30, 2021

Barbeque-Nation Hospitality Ltd (543283) – Debt-free at the net level

Barbeque-Nation Hospitality Ltd (543283) closes   at 853.00  with  a   Fall  of   -2.80%   on    28-May-2021  with formation of  a  Small  Red  Candle    on Daily  Price Chart.

About the Company : Incorporated in 2006, Barbeque Nation is one of the leading casual dining chains in India. Barbequ Nation Hospitality Limited (BNHL) is a pioneer in "over the table barbeque" live grills embedded in dining tables

Strength : The recent fund-raising by BNHL (pre- and post-IPO) has strengthened its balance sheet and the company is debt-free at the net level. Timely liquidity infusion will enable the company to survive the second wave and emerge stronger, once the pandemic recedes.

 

Financials : Barbeque-Nation Hospitality Ltd  has posted Net Sales / Revenue   of  507.10 Cr & Net Loss  of -90.50 Cr in FY2021 and expected to post Net Sales / Revenue   of 897.50 Cr & Net Profit of 5.10 Cr in FY2022 & Net Sales / Revenue   of 1095.00 Cr & Net Profit of 5.98Cr in FY2023

Valuations  : The Company is now Trading at X 37.50   of its  valuations of its FY2022 earnings and X5.98 of its FY2023 earnings.

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  -0.70  which  makes is attractive after a ~50% fall in market price. The  Equity Value Per Share ( Enterprise Value Method ) is  784.10

 

If We factor its earnings/valuations, its Price arrives at 1064 with consideration FY2022 earnings.

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source NSE Website | Screener.In  | Capital Line Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

Manage your investments the right way With MProfit. Visit https://www.mprofit.in/

Use Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

 


Saturday, May 29, 2021

KMC Speciality Hospitals (India) Ltd (524520) – Benefiting from COVID-19

KMC Speciality Hospitals (India) Ltd (524520) closes   at 39.70 with  a   Fall  of   - 1.40%   on    28-May-2021  with formation of  a  Red  Candle    on Daily  Price Chart.

About the Company : KMC Specialty Hospitals India Limited (KMCL), established in 1982, is a part of the Kauvery Group of Hospitals based at Tiruchirappalli (Trichy). The company runs Kauvery Hospital, a 220 bed super specialty hospital that offers services in neurology, obstetrics & gynecology, pediatrics, cardiology, ENT, dental, joint replacement among others. Further, during FY2018, the company also started lever transplantation services in the hospital. Kauvery group of hospitals is one of the reputed hospital chain with about 1200 beds across Tamil Nadu. KMC is a publicly listed company with Bombay Stock Exchange

Sector Update : Positive

Strength :  1. Experienced management and establish presence

2.. Comfortable financial risk profile

Weaknesses : 1. Moderate scale within the industry, geographical concentration risk and intense competition ( KMC operates only one hospital with 220 beds; the same are modest within the industry dominated by large players like Apollo Hospitals, CARE Hospitals among others. Further, KMC’s entire revenues are skewed from a single location property. Any unforeseen eventuality will impact the entire business and financial risk profile of the company. Though KMC has a brand ‘Kauvery’ in the State of Tamil Nadu with a chain of hospitals with aggregate bed capacity of about 1200, however KMC Hospital at Trichy remain under pressure and faces competition from other leading hospitals in the vicinity as reflected in volatile operating margins )

2. Project execution risk (The company has proposed a new project to setup a Mother and Child Health Care hospital which is under construction. However it was delayed due to Covid for a period of 6 months due to lockdown and now it is expected to be completed by April 2023. The cost of the project is around Rs. 75 to 80 crores of which Rs.50 - 60 crores will be provided by the bank and the balance Rs. 25.00 crores will be funded through internal accruals and promoters )

Financials : KMC Speciality Hospitals (India) Ltd  has posted Net Sales / Revenue   of 103.00 Cr & Net Profit of 13.00 Cr in FY2021 .

Valuations  : The Company is now Trading at X 3.0  of its  valuations ( FY2021 earnings considered here) with ~200 % premium ( While Apollo Hospitals Enterprise Ltd is Trading X6.0 of its Valuations )

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  0.50  which  makes is attractive after a ~50% fall in market price. The  Equity Value Per Share ( Enterprise Value Method ) is  39.70

Whats  best in It   :It has passed on the indicator Growth Candidate ( If >1 ), which is now 1.1 and Future Stocks Price  Upmove Start Index ( FSPUI ) Decline after Up which is a good Indicators for a Multibagger.

If We factor its earnings/valuations, its Price arrives at 54.20 with consideration FY2022 earnings (Historical 10Yrs Growth Rate basis ).

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source NSE Website | Screener.In  | Capital Line Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

 

Manage your investments the right way With MProfit. Visit https://www.mprofit.in/

Use Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

 

 


Friday, May 28, 2021

Automobiles : FY22E Estimate Sales Growth %



Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source NSE Website | Screener.In  | Capital Line Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

 

Manage your investments the right way With MProfit. Visit https://www.mprofit.in/

Use Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

 


Wednesday, May 26, 2021

Crompton Greaves Consumer Electricals Ltd (539876) – Gaining Market Share

Crompton Greaves Consumer Electricals Ltd (539876) is Trading  at 399.45  with  a  Loss  of  -0.9%   on    26-May-2021  with formation of  a  Red  Candle    on Daily  Price Chart at the time of writing this article.

About the Company : Crompton Greaves Consumer Electricals Limited is one of the leading consumer companies in India with a 75+ years old brand legacy. It is an independent company under professional management and have 2 business segments – Lighting and Electrical Consumer Durables. We market our products under the “Crompton” brand name in India and select export markets

Sector Update : Stable

Strength :  1. The company gained a 1 per cent share in fans from smaller players in FY21 with its current share at 28 per cent

2.. All the main consumer product categories such as fans, appliances and pumps which make up 78 per cent of revenues reported robust growth ranging from 59-74 per cent. Growth in the lighting segment was led by consumer lighting which grew by 41 per cent.

3. It has also outperformed the sector growth across segments such as pumps, mixer grinders and air coolers.

Financials : Crompton Greaves Consumer Electricals Ltd  has posted Net Sales / Revenue   of 4803.50 Cr & Net Profit of 141.10 Cr in FY2020 and expected to post Net Sales / Revenue   of 1358.60 Cr & Net Profit  of 616.70 Cr in FY2021 and expected to post Net Sales / Revenue   of 5429.40 Cr & Net Profit of 573.90 Cr in FY2022 & Net Sales / Revenue of 6521.50 Cr & Net Profit of 744.10 Cr in FY2023.

Valuations  : The Company is now Trading at X 32.50  of its  valuations ( FY2021 earnings considered here) with ~150 % premium and at X2.66  of its FY 2022, which is almost  ~166%  premium   to its value and  X 2.05  of its FY 2023 earning with a  Premium  of ~105%  of its FY2023 earning .

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  0.60  which  makes is attractive after a ~40% fall in market price. The  Equity Value Per Share ( Enterprise Value Method ) is  393.50

Whats  best in It   : Strong growth, higher cash flows due to efficient working capital management and improving balance sheet are positives will  help it to capitalise on pent up demand once normalcy returns.

If We factor its earnings/valuations, its Price arrives at 491.00 with consideration FY2023 earnings.

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source NSE Website | Screener.In  | Capital Line Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |


Sunday, May 23, 2021

Macrotech Developers Ltd (543287) – A debt-free company in next three years

Macrotech Developers Ltd (543287) closes   at 644.30  with  a   Gain  of   +2.60%   on    21-May-2021  with formation of  a  Green  Candle    on Daily  Price Chart.

About the Company : Macrotech Developers Limited, formerly Lodha Developers Limited, is a residential developer. It is engaged in developing real estate across the residential and commercial sectors in the Mumbai, Pune and in London. Its residential portfolio comprises of luxury, high-end and aspirational developments. It also develops office and retail projects across markets as standalone developments and in mixed-use format. It is developing several apartment projects, such as the World Towers at Lower Parel, Trump Tower Mumbai at Worli and Lodha Altamount at Altamount Road. In its high-end residential category, it is developing projects, such as The Park at Worli, Lodha Venezia at Parel, and New Cuffe Parade at Wadala. Aspirational residential category consists of several projects, including Lodha Eternis at Andheri, Lodha Luxuria Priva at Thane, Lodha Splendora at Thane and Lodha Belmondo at Pune. Its brands include Lodha, Lodha Luxury and Palava.

Strength : 1.Macrotech Developers is targeting to bring down its net debt to zero over the next three years from the current borrowing level of around Rs 16,000 crore

2..Cos will do Rs 9,000 crore or upward of sales for FY2022.

3. Company will double its investment on construction to Rs 2,800 crore in this fiscal.

Financials : Macrotech Developers Ltd has posted Net Sales / Revenue   of ₹ 5449.00 Cr & Net Profit of 40.00Cr in FY2021 and expected to post Net Sales / Revenue   of ₹9000.00 Cr & Net Profit of 1927.80 Cr in FY2022.

 

Valuations  : The Company is now Trading at X 43.50  of its  valuations ( FY2021  earnings considered here) and at X0.90 of its FY 2022 earnings , which is now almost  ~10%  Discount.   

Growth Rate for this cos is 160%, which justify its higher multiple valuation,

If We factor its earnings/valuations, its Price arrives at 714 with consideration FY2022 earnings.

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source NSE Website | Screener.In  | Capital Line Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

 

 


Disclaimer

The recommendations made herein do not constitute an offer to sell or a solicitation to buy any of the securities mentioned. No representations can be made that the recommendations contained herein will be profitable or that they will not result in losses. Readers using the information contained herein are solely responsible for their actions. Information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on the theory of Technical Analysis and do not reflect the fundamental validity of the Scrip. www.niftynext..com does 't take any Responsibility for any losses arising from using the Stocks Recommendations.
We( WWW.NIFTYNEXT.COM) are not Registered with Any Regulatory Body in India ie SEBI,NSE,BSE,AMFI or Any Otheres.


Blog Archive